BGAM
ELV icon

Boussard & Gavaudan Asset Management’s Elevance Health ELV Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,385
Closed -$258K – 22
2014
Q2 		$258K Sell
2,385
-65
-3% -$6.7K 0.13% 43
2014
Q1 		$244K Sell
2,450
-26
-1% -$2.35K 0.15% 48
2013
Q4 		$229K Buy
+2,476
New +$220K 0.16% 56

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Boussard & Gavaudan Asset Management's ELV Position: Q3 2014 in Review

Boussard & Gavaudan Asset Management sold out of Elevance Health (ELV) in Q3 2014, closing a stake of 2,385 shares — an estimated $258K sold.

Boussard & Gavaudan Asset Management first reported a position in ELV in Q4 2013 and held it in 3 quarters. The position peaked at $258K in Q2 2014. 707 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Elevance Health position as of Q3 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 2,385 Elevance Health shares in Q3 2014, an estimated $258K.
  • Boussard & Gavaudan Asset Management first reported a position in Elevance Health in Q4 2013 and held it in 3 quarters.
  • Boussard & Gavaudan Asset Management's Elevance Health position peaked at $258K in Q2 2014.
  • 707 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q3 2014.